Biogen, Ionis tout data from early study of RNA-based Alzheimer's drug

Biogen, Ionis tout data from early study of RNA-based Alzheimer's drug

Source: 
BioPharma Dive
snippet: 

Biogen and Ionis Pharmaceuticals said Monday that one of their experimental drugs for Alzheimer's disease has shown early signs of being safe and effective.